drugset / Trial / NCT07198555
A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of BBM-A101 in the Treatment of Knee Osteoarthritis.
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of the study is to evaluate the safety, tolerability, and efficacy of BBM-A101 to treat participants with knee osteoarthritis.
Timeline
- Start
- 2025-10-09
- Primary completion
- 2027-12-30
- Completion
- 2031-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BBM-A101 | Gene therapy (AAV / viral vector) | — | Other |